Correction: Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER database.

Autor: Claire Faltermeier, Timothy Chai, Sharjeel Syed, Nathan Lau, Lior Elkaim, George Ibrahim, Anthony Wang, Alexander Weil, Anne Bendel, Aria Fallah, Albert Tu

Publikováno v: PLoS ONE, Vol 14, Iss 10, p e0224570 (2019)

[This corrects the article DOI: 10.1371/journal.pone.0223051.].

Externí odkaz: https://doaj.org/article/6182878b870c47a0816c55b9e8450789

Cerebellar Mutism Syndrome in Children After Surgery for a Posterior Fossa Tumor: Patient Characteristics and Recovery

Autor: Melissa Hansen, Anne Bendel, Julie Ann Blabolil, Mary C. Hooke

Publikováno v: Journal of Pediatric Hematology/Oncology Nursing. 39:243-249

Background: Cerebellar mutism syndrome (CMS) is a potential complication that may be experienced by children undergoing a resection of a posterior fossa tumor. Symptoms include mutism and emotional lability; additional symptoms may include hypotonia,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2517bfeec306f51cde73f5bccd2912ed
https://doi.org/10.1177/27527530211074257

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

Autor: Lee Yi Yen, Melyssa Aronson, Carol J. Swallow, Cynthia Hawkins, Lara Reichman, Rebecca C. Luiten, Sumita Roy, Michal Zapotocky, Patrick Tomboc, Christian Kratz, Michael Osborn, Junne Kamihara, Ayse Bahar Ercan, Jamie L. Maciaszek, Vanessa Bianchi, Benjamin Oshrine, Hagit N. Baris, Ossama M. Maher, Mohsin Rashid, Sara Rhode, Sharon Gardner, Annika Bronsema, David S. Ziegler, An Van Damme, Monica Newmark, Mithra Ghalibafian, Heather Hampel, Jordan R. Hansford, Vahid Fallah Azad, Michael P. Link, Simon C. Ling, Marc Remke, Shayna Zelcer, Deborah T. Blumenthal, Isabelle Scheers, Rebecca Loret De Mola, Syed Ahmer Hamid, Vanan MagimairajanIssai, Kim E. Nichols, Saunders Hsu, Catherine Goudie, Naureen Mushtaq, Ira Winer, Abeer Al-Battashi, Garth Nicholas, Roula Farah, Kami Wolfe Schneider, Rejin Kebudi, Jan Rapp, Gregory Thomas, Helen Toledano, Alvaro Lassaletta, Anne Bendel, Jeffrey Knipstein, Musa Alharbi, Gadi Abebe-Campino, Rose B. McGee, Anirban Das, Uri Tabori, Donald Basel, Alyssa Reddy, Melissa Edwards, Scott Lindhorst, Craig Harlos, Bailey Gallinger, Elizabeth Cairney, Anita Villani, Valerie Larouche, Rachel Pearlman, Maude Blundell, Gary Mason, David Sumerauer, Magnus Sabel, Aghiad Chamdin, Leslie Taylor, David Malkin, William D. Foulkes, Maura Massimino, Catherine Gilpin, Eric Bouffet, Miriam Bornhorst, Carol Durno, Enrico Opocher, Nobuko Hijiya, Zehavit Frenkel, David Samuel, Michal Lurye, Stefanie Zimmermann, Shani Caspi, Stefano Chiaravalli, David Gass, Eshetu G. Atenafu, Shlomi Constantini, Shay Ben-Shachar, Michal Yalon, Rina Dvir, Daniel Pettee, Bruce Crooks, Santanu Sen, Carl Koschmann, Raymond Bedgood, Theodore Nicolaides, Duncan Stearns, Yael Goldberg, Melissa Galati, Gabriel Robbins

Publikováno v: Paediatrics Publications
Journal of Clinical Oncology, Vol. 39, no.25, p. 2779-2790 (2021)

PURPOSE Constitutional mismatch repair deficiency syndrome (CMMRD) is a lethal cancer predisposition syndrome characterized by early-onset synchronous and metachronous multiorgan tumors. We designed a surveillance protocol for early tumor detection i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc31eca9b2efe8b55ac14084ca85e170
https://doi.org/10.1200/jco.20.02636

Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials

Autor: Sridharan Gururangan, David W. Ellison, Ibrahim Qaddoumi, Sandeep Kumar Dhanda, Santhosh A. Upadhyaya, Robert P. Sanders, Tim Hassall, Marcel Kool, Pascal Johann, Arzu Onar-Thomas, Anne Bendel, Catherine A. Billups, Gang Wu, Anna Vinitsky, Zoltan Patay, Sonia Partap, Daniel J. Indelicato, Gregory T. Armstrong, Ashok Srinivasan, John R. Crawford, Paul G. Fisher, Paul Klimo, Giles W. Robinson, Alberto Broniscer, Eric Bouffet, Frederick A. Boop, Kim E. Nichols, Ruth G. Tatevossian, Roya Mostafavi, Murali Chintagumpala, Brent A. Orr, Amar Gajjar, Thomas E. Merchant

Publikováno v: Clin Cancer Res

Purpose: Report relevance of molecular groups to clinicopathologic features, germline SMARCB1/SMARCA4 alterations (GLA), and survival of children with atypical teratoid rhabdoid tumor (ATRT) treated in two multi-institutional clinical trials. Materia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c6ac5f822d08b96d3e96afa2bba389
https://doi.org/10.1158/1078-0432.ccr-20-4731

LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study

Autor: Nathan Robison, Jasmine Pauly, Jemily Malvar, Sharon Gardner, Jeffrey Allen, Ashley Margol, Tobey MacDonald, Anne Bendel, Lindsay Kilburn, Andrew Cluster, Daniel Bowers, Kathleen Dorris, Nicole Ullrich, Rebecca Loret De Mola, Elizabeth Alva, Sarah Leary, Patricia Baxter, Ziad Khatib, Kenneth Cohen, Tom Belle Davidson, Ashley Plant, Pratiti Bandopadhayay, Sylwia Stopka, Nathalie Agar, Karen Wright, Marvin Nelson, Yueh-Yun Chi, Mark Kieran

Publikováno v: Neuro-Oncology. 24:i191-i192

BACKGROUND RAS/RAF/MEK/ERK pathway activation is the primary driver for most pediatric low-grade gliomas (pLGG). MEK162 (binimetinib) is an orally bioavailable MEK1/2 inhibitor with superior brain penetration in a preclinical model. The primary objec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8d9d41b1b9c0e99c7f64fccdbe24fe75
https://doi.org/10.1093/neuonc/noac079.716